DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Russell-Jones D, Cuddihy RM, Hanefeld M et al.
Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study.
Diabetes Care 2012;
35: 252-258
Access:
We do not assume any responsibility for the contents of the web pages of other providers.